<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on intellectual property interests from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated intellectual property interests news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 11:50:58 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=intellectual+property+interests" rel="self" type="application/rss+xml" />

	
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038929&amp;HITNO=0&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038929&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537838669%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038929&amp;HITNO=0&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038929&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537838669%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Sequenom Licenses Worldwide Rights To Develop Age-Related Macular Degeneration Diagnostic Test</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4040873&amp;HITNO=1&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4040873&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538908520%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4040873&amp;HITNO=1&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4040873&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538908520%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
<item><title>Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4040263&amp;HITNO=2&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4040263&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538679324%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4040263&amp;HITNO=2&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4040263&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538679324%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039970&amp;HITNO=3&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039970&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538503558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039970&amp;HITNO=3&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039970&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538503558%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Ingen Takes Final Steps Towards Increased Export Sales</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036679&amp;HITNO=4&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036679&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536702262%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036679&amp;HITNO=4&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036679&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536702262%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036885&amp;HITNO=5&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036885&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536813401%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036885&amp;HITNO=5&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036885&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536813401%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035958&amp;HITNO=6&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035958&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536433004%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035958&amp;HITNO=6&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035958&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536433004%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034924&amp;HITNO=7&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034924&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536050009%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034924&amp;HITNO=7&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034924&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536050009%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034898&amp;HITNO=8&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034898&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536030336%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034898&amp;HITNO=8&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034898&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536030336%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FinanzNachrichten.de:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036217&amp;HITNO=9&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036217&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536535210%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036217&amp;HITNO=9&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036217&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536535210%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>RBC Dain Rauscher:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035238&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035238&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536163268%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035238&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035238&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536163268%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034976&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034976&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536072300%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034976&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034976&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536072300%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>RealNetworks and Viacom to Separate Rhapsody Into Independent Company</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038435&amp;HITNO=12&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038435&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537607717%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038435&amp;HITNO=12&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038435&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537607717%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035761&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035761&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536357500%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035761&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035761&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536357500%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Charlotte Business Journal:</description></item>
<item><title>Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035760&amp;HITNO=14&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035760&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536357481%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035760&amp;HITNO=14&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=intellectual%20property%20interests&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035760&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536357481%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Denver Business Journal:</description></item>
</channel></rss>